In December 2016, the U.S. Food & Drug Administration (FDA) issued a warning letter to Northern Health Products, Inc. (NHP), a dietary supplement company, for selling products to cure, prevent or treat cancer in humans or animals without prior FDA approval, in violation of law. Among the products are DCA Cancer Treatment Kit (Sodium Dichloroacetate and Thiamine Vitamin 81), ALA Alpha Lipoic Acid, N-A-C N-Acetyl L-Cysteine, DMSA Synergy, and DCA (sodium dichloroacetate) also referred to as “Pet DCA.” Because NHP was marketing these products for use in the cure, prevention, and treatment of a disease, in particular, cancer, the FDA said they qualify as drugs. And because the products have not been subjected to the FDA’s rigorous review for drugs, the safety and effectiveness of the products have not been evaluated. The FDA also cautioned that the drugs were misbranded in that they failed to provide adequate directions for their intended use. If you purchased any of these products on the promise that they prevent or cure cancer, you may have a claim against NHP for false labeling and advertising. Please contact FBFG to evaluate your rights. FBFG attorneys have successfully prosecuted claims and obtained settlements on behalf of victims of false labeling and advertising.
